Main content area

Diversity and bioprospecting of culturable actinomycetes from marine sediment of the Yellow Sea, China

Xiong, Zhi-Qiang, Liu, Qiao-Xia, Pan, Zhao-Long, Zhao, Na, Feng, Zhi-Xiang, Wang, Yong
Archives of microbiology 2015 v.197 no.2 pp. 299-309
Kocuria, Micromonospora, Nocardiopsis, Saccharomonospora, Streptomyces, anti-infective properties, diketopiperazines, drug resistance, drugs, genes, marine sediments, microorganisms, phylogeny, polymerase chain reaction, pretreatment, ribosomal RNA, screening, seawater, secondary metabolites, statistical analysis, China, Yellow Sea
Marine actinomycetes are a potential source of a wide variety of bioactive natural products. In this work, seven pretreatments, three selective isolation media, and five artificial seawater concentrations were used to isolate actinomycetes from the sediments collected from Yellow Sea, China. Statistical analysis showed that only the isolation medium strongly affected the total and bioactive numbers of actinomycete isolates. A total of 613 actinobacterial strains were isolated and screened for antimicrobial activities; 154 isolates showed activity against at least one of nine test drug-resistant microorganisms. Eighty-nine representatives with strong antimicrobial activity were identified phylogenetically based on 16S rRNA gene sequencing, which were assigned to five different actinomycete genera Streptomyces, Kocuria, Saccharomonospora, Micromonospora, and Nocardiopsis. Using PCR-based screening for six biosynthetic genes of secondary metabolites, all 45 isolates with acute activity have at least one biosynthetic gene, 28.8 % of which possess more than three biosynthetic genes. As a case, strain SMA-1 was selected for antimicrobial natural product discovery. Three diketopiperazine dimers including a new compound iso-naseseazine B (1) and two known compounds naseseazine B (2) and aspergilazine A (3) were isolated by bioassay-guided separation. These results suggested that actinomycetes from marine sediments are a potential resource of novel secondary metabolites and drugs.